Osteoarthritis in dogs: does low-level laser therapy (photobiomodulation) versus sham improve pain and function? — POSSIBLE

In dogs with osteoarthritis, does low-level laser therapy vs sham improve pain and function scores?

Shelf #515 · gate-verified and displayed under the developer's blinded-trial rule

POSSIBLE: In dogs with naturally occurring elbow osteoarthritis, photobiomodulation therapy (PBMT, 10 to 20 J/cm² to both elbows for 6 weeks) beat sham light therapy (0 J/cm²) in a randomised, blind, placebo-controlled trial of 20 dogs (Looney 2018, PMID: 30197438): NSAID dose reduction occurred in 9/11 PBMT dogs versus 0/9 sham dogs (P = 0.0003), lameness score improved more after PBMT (P = 0.001), and a greater reduction in pain score was detected in 9 of 11 parameters in the PBMT group (P < 0.05). Design class (a): randomisation and blinding are established by the pivotal record's own wording ('a randomized blind placebo-controlled trial'; MeSH: Random Allocation) and the record answers the shelf's own comparison (laser versus sham) in the shelf's own population (dogs with osteoarthritis). The stamp is POSSIBLE, not higher, because the entire sham-controlled evidence base carded here is this single small trial (11 versus 9 dogs, elbow osteoarthritis only, outcomes assessed 7 to 10 days after the last of 6 weeks of treatment): it does not cover other joints, other laser doses or devices, or durability beyond that short window, and the pain finding is reported as 9 of 11 parameters improved rather than as a single prespecified pain score with absolute values in the abstract. Records testing PBMT against meloxicam rather than sham, and uncontrolled PBMT series, exist but answer different questions and are not carded as claim-carriers (see synthesis watchOut). Drafted Nov 10, 2026 (VetMed build, topic #515); all figures from the abstract fetched and verified at drafting.

Looney 2018: photobiomodulation beat sham in 20 dogs with elbow osteoarthritis — NSAID dose reduced in 9/11 laser dogs versus 0/9 sham dogs (P = 0.0003), lameness improved more (P = 0.001), and pain score fell more in 9 of 11 parameters (P < 0.05)

Randomized blind placebo-controlled trial (record's own wording, in its title; publication types: Clinical Trial, Veterinary, Journal Article, Multicenter Study)

Who: Dogs: 20 dogs with naturally occurring elbow osteoarthritis in a multicentre clinical setting. Dogs were randomly assigned to photobiomodulation therapy (PBMT group, n = 11) at 10 to 20 J/cm² or placebo sham light treatment (group S, n = 9) at 0 J/cm², applied to both elbows for 6 weeks. Lameness score, pain score and NSAID dose were recorded by blinded study personnel before treatment and 7 to 10 days after the last treatment.

Result: Reduction in NSAID dose occurred in 9/11 dogs in the PBMT group and in 0/9 dogs in the sham group (P = 0.0003). There was greater improvement in lameness score post PBMT versus sham therapy (P = 0.001). A greater reduction in pain score was detected in 9/11 parameters in the PBMT group (P < 0.05). The authors conclude that regularly scheduled PBMT at 10 to 20 J/cm² per joint for 6 weeks was successful in improving lameness and pain scores and in lowering NSAID requirement in canine elbow osteoarthritis patients.

Watch out: A single small trial (11 versus 9 dogs) restricted to elbow osteoarthritis, one dose range (10 to 20 J/cm²) and one 6-week schedule, with outcomes measured only 7 to 10 days after the final treatment — it says nothing about hip or stifle osteoarthritis, other laser devices or doses, or how long the benefit lasts. The abstract reports the pain result as a count of improved parameters (9 of 11) rather than absolute score values, and the striking NSAID-sparing contrast (9/11 versus 0/9) rests on very small denominators, so a few dogs changing group outcome would move it substantially.

Looney AL, Huntingford JL, Blaeser LL, Mann S. A randomized blind placebo-controlled trial investigating the effects of photobiomodulation therapy (PBMT) on canine elbow osteoarthritis. Can Vet J. 2018;59(9):959-966. PMID: 30197438. Registry ID: none in the record. MeSH: Animals · Anti-Inflammatory Agents, Non-Steroidal/therapeutic use · Dogs · Female · Forelimb · Lameness, Animal/therapy · Low-Level Light Therapy/veterinary* · Male · Osteoarthritis/therapy, veterinary* · Pain/drug therapy, veterinary* · Prospective Studies · Random Allocation

Synthesis: one small randomised blind sham-controlled trial favours photobiomodulation for elbow osteoarthritis pain, lameness and NSAID-sparing — POSSIBLE

Synthesis

Who: Synthesis of the card above: Looney 2018 (20 dogs with naturally occurring elbow osteoarthritis, PBMT 10 to 20 J/cm² versus sham 0 J/cm² to both elbows for 6 weeks, blinded assessment). No other sham-controlled record in canine osteoarthritis was carded.

Result: (1) NSAID requirement: dose reduction in 9/11 PBMT dogs versus 0/9 sham dogs (P = 0.0003). (2) Function: greater improvement in lameness score after PBMT than sham (P = 0.001). (3) Pain: greater pain-score reduction in 9 of 11 parameters in the PBMT group (P < 0.05). (4) Scope: all three findings come from this one 20-dog elbow-osteoarthritis trial; sham-controlled evidence for other joints, doses and longer follow-up was not found.

Watch out: One-home check at drafting: PMID: 30197438 does not appear in any other pack on disk. Records deliberately not carded as claim-carriers: Alves 2022 (PMID: 35895799), a randomised double-blinded trial in 20 dogs with bilateral hip osteoarthritis — but its control was a 21-day course of meloxicam, not sham, so it answers a different comparison; Barale 2020 (PMID: 32426264), a retrospective uncontrolled series of 17 dogs, and Tomlinson-type uncontrolled activity data (PMID: 36377757, 23 dogs, no comparator) — neither can separate laser effect from time, concurrent analgesia titration or placebo-by-proxy effects. Post-surgical laser trials after tibial plateau leveling osteotomy (PMIDs: 30058855, 29697148) concern postoperative recovery in cruciate disease, not osteoarthritis pain management, and home on their own questions if built.

Synthesis of Looney AL et al. PMID: 30197438. Registry ID as on the individual card.

Back to the library index · VetMed home

VetMed is an educational resource, not veterinary advice.